Matches in Wikidata for { <http://www.wikidata.org/entity/Q65345221> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q65345221 description "clinical trial" @default.
- Q65345221 description "ensayu clínicu" @default.
- Q65345221 description "klinisch onderzoek" @default.
- Q65345221 description "клінічне випробування" @default.
- Q65345221 name "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 name "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 type Item @default.
- Q65345221 label "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 label "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 prefLabel "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 prefLabel "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU" @default.
- Q65345221 P1050 Q65345221-CDE1176D-A3F3-495E-8C0E-A58580E0D589 @default.
- Q65345221 P1132 Q65345221-16C72C19-57EF-4835-83F2-15038BE472AA @default.
- Q65345221 P1476 Q65345221-8264202A-4A3A-4A11-A4C2-0C9608E0997A @default.
- Q65345221 P17 Q65345221-3624393F-9C8E-4254-8A41-7B1135A49C2F @default.
- Q65345221 P17 Q65345221-37775265-21C2-4A93-91C2-12F1FDA59856 @default.
- Q65345221 P17 Q65345221-4AAC8A66-3B78-4614-B6D1-00956F8C74FF @default.
- Q65345221 P17 Q65345221-5BB4CDA6-5899-4092-B8CE-96380F24A4A8 @default.
- Q65345221 P17 Q65345221-5E077A74-8E30-42CE-AC3E-8E8AA25EAC8D @default.
- Q65345221 P17 Q65345221-9A77CA68-55BC-44C9-A70A-3E26B2517039 @default.
- Q65345221 P17 Q65345221-B7ACFD77-DC6B-4E80-88EF-FF4D7763F879 @default.
- Q65345221 P17 Q65345221-E510A118-B8E0-4297-A0C4-E3D9074DD8B4 @default.
- Q65345221 P17 Q65345221-EC75A0E4-1F64-4BB4-9B0A-C33C5D34CF50 @default.
- Q65345221 P2899 Q65345221-91E8B613-852F-478F-BE32-AC4357852D41 @default.
- Q65345221 P3098 Q65345221-582FAD30-5279-444C-A619-EED8AD910D0D @default.
- Q65345221 P31 Q65345221-79ECF054-62C1-4660-B421-D043E979CE4C @default.
- Q65345221 P4135 Q65345221-30247C1D-4097-4EFD-BD1F-3C1631271EA3 @default.
- Q65345221 P580 Q65345221-EC066AD2-C151-43EE-88A3-97F1E4D47F0D @default.
- Q65345221 P582 Q65345221-1FF57D1A-4A73-456E-8093-0BDBA0C2A087 @default.
- Q65345221 P6099 Q65345221-2CD8F0EA-05B3-4858-B32C-6121F892FF3E @default.
- Q65345221 P6153 Q65345221-FBEF26E7-DC25-498B-BC79-D22DF10FD54D @default.
- Q65345221 P8363 Q65345221-13ADB5FC-A51A-4E95-AA7E-3CA0CFF6B45A @default.
- Q65345221 P859 Q65345221-3BC771AE-2ADD-4119-B7A7-19D16D8D2C2E @default.
- Q65345221 P921 Q65345221-C9953FB7-F154-412E-A4BB-298DC27FC2C2 @default.
- Q65345221 P1050 Q187440 @default.
- Q65345221 P1132 "+382" @default.
- Q65345221 P1476 "A Multi-center, Randomized, Double-blind, Placebo, and Active-controlled Phase 2b Dose-finding Study of QGE031 as add-on Therapy to Investigate the Efficacy and Safety in Patients With Chronic Spontaneous Urticaria (CSU)" @default.
- Q65345221 P17 Q145 @default.
- Q65345221 P17 Q16 @default.
- Q65345221 P17 Q17 @default.
- Q65345221 P17 Q183 @default.
- Q65345221 P17 Q29 @default.
- Q65345221 P17 Q30 @default.
- Q65345221 P17 Q408 @default.
- Q65345221 P17 Q41 @default.
- Q65345221 P17 Q865 @default.
- Q65345221 P2899 "+18" @default.
- Q65345221 P3098 "NCT02477332" @default.
- Q65345221 P31 Q30612 @default.
- Q65345221 P4135 "+75" @default.
- Q65345221 P580 "2015-07-15T00:00:00Z" @default.
- Q65345221 P582 "2016-11-02T00:00:00Z" @default.
- Q65345221 P6099 Q42824440 @default.
- Q65345221 P6153 Q507154 @default.
- Q65345221 P8363 Q78089383 @default.
- Q65345221 P859 Q507154 @default.
- Q65345221 P921 Q6545898 @default.